Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral: Vanier Canada Graduate Scholarships

University of Toronto

$150,000.00

Characterizing the mechanisms of glutamate-mediated activation of spinal cord neural stem/progenitor cells to reveal therapeutic targets for spinal cord injury

EF 2020-21

Résumé
Spinal cord injury (SCI) is a devastating condition with currently no available treatment options. A number of stem cell-based therapies have been examined to promote regeneration and recovery after SCI but all have been limited by minimal neuronal differentiation and a lack of functional connectivity. Overcoming these barriers is essential in translating effective stem cell therapies to patients. The adult spinal cord contains a population of endogenous neural stem/progenitor cells (NSPCs) that proliferate after injury thus providing a promising source of endogenous repair potential. However, the mechanisms that activate spinal cord NSPCs previously remained unknown and strategies to promote their functional integration into neural networks have been limited. Recently, I demonstrated that the excitatory neurotransmitter glutamate plays a key role in the activation and neuronal differentiation of this population of stem cells by way of the AMPA receptor. The downstream mechanisms of this effect have yet to be characterized. In the proposed project, I will characterize the mechanisms involved in glutamate-mediated activation of adult human spinal cord NSPCs. I will determine the changes in glutamate receptor expression induced in NSPCs after injury. Furthermore, I will test the therapeutic potential of positive AMPA receptor modulator drugs in promoting NSPC survival and neuronal differentiation after SCI. This work will uncover important mechanisms to enhance stem cell neurogenesis and integration into functional neural networks in order to ultimately advance the clinical translation of stem cell therapies to SCI patients.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
437165
Name
Hachem Laureen D
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Characterizing the mechanisms of glutamate-mediated activation of spinal cord neural stem/progenitor cells to reveal therapeutic targets for spinal cord injury
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Ampa Receptor Modulation; Glutamate Signaling; Plasticity; Spinal Cord Injury; Stem Cells
Abstract
Spinal cord injury (SCI) is a devastating condition with currently no available treatment options. A number of stem cell-based therapies have been examined to promote regeneration and recovery after SCI but all have been limited by minimal neuronal differentiation and a lack of functional connectivity. Overcoming these barriers is essential in translating effective stem cell therapies to patients. The adult spinal cord contains a population of endogenous neural stem/progenitor cells (NSPCs) that proliferate after injury thus providing a promising source of endogenous repair potential. However, the mechanisms that activate spinal cord NSPCs previously remained unknown and strategies to promote their functional integration into neural networks have been limited. Recently, I demonstrated that the excitatory neurotransmitter glutamate plays a key role in the activation and neuronal differentiation of this population of stem cells by way of the AMPA receptor. The downstream mechanisms of this effect have yet to be characterized. In the proposed project, I will characterize the mechanisms involved in glutamate-mediated activation of adult human spinal cord NSPCs. I will determine the changes in glutamate receptor expression induced in NSPCs after injury. Furthermore, I will test the therapeutic potential of positive AMPA receptor modulator drugs in promoting NSPC survival and neuronal differentiation after SCI. This work will uncover important mechanisms to enhance stem cell neurogenesis and integration into functional neural networks in order to ultimately advance the clinical translation of stem cell therapies to SCI patients.
Competitiondate
202011
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Hachem, Laureen D
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~